CDK inhibitors and their use as pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12129262
APP PUB NO 20220267345A1
SERIAL NO

17554284

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure is directed to compounds of Formula I

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRELUDE THERAPEUTICS INCORPORATED175 INNOVATION BOULEVARD WILMINGTON DE 19805

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buesking, Andrew W Wilmington, US 28 373
Combs, Andrew Paul Kenneth Square, US 21 79
Holmes, Ryan Wilmington, US 17 72
Pawley, Sarah Landenberg, US 5 2
Rohlfing, Katarina Conshohocken, US 11 10
Wu, Xiaowei Wilmington, US 87 1823

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 29, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 29, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 29, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00